0000899243-17-024074.txt : 20171011
0000899243-17-024074.hdr.sgml : 20171011
20171011191313
ACCESSION NUMBER: 0000899243-17-024074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171009
FILED AS OF DATE: 20171011
DATE AS OF CHANGE: 20171011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poma Eric E
CENTRAL INDEX KEY: 0001339484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 171133556
MAIL ADDRESS:
STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC.
STREET 2: 555 MADISON AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-09
0
0001183765
Molecular Templates, Inc.
MTEM
0001339484
Poma Eric E
C/O MOLECULAR TEMPLATES, INC.
9301 AMBERGLEN BLVD., SUITE 100
AUSTIN
TX
78729
1
1
0
0
See Remarks
Stock Option (right to buy)
9.40
2017-10-09
4
A
0
275000
0.00
A
2027-10-09
Common Stock
275000
275000
D
25% of the total number of shares subject to the option shall vest on October 9, 2018, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months.
Chief Executive Officer and Chief Scientific Officer
/s/ Jason S. Kim, Attorney-in-fact
2017-10-11